In recognition of National Stroke Awareness Month, Astrazeneca will launch a web site aimed at educating the public about the risk of stroke associated with Atrial Fibrillation also called A.F. Each year, about seven-hundred-thousand people experience new or recurrent stroke. Patients with Atrial Fibrillation, or A-F, a type of irregular heart beat, are five times more likely to suffer a stroke than those without A-F A new survey shows that more than 80 percent of one thousand people polled were not aware that A-F is a major risk factor for stroke. A new educational resource has been developed to help raise awareness of this condition and medications that may help decrease the risk of strokes associated with A-F. Doctor Jodie Hurwitz, Medical City Dallas Hospital:

"Knowledge is key � talk to your doctor and visit a-f advisor dot org. This web site was developed by a team of medical experts and a patient advocate from six leading institutions and Astrazeneca to provide information on A-F and its link to stroke. Many A-F related-strokes may be prevented through treatment with anticoagulants, but you have to be diagnosed with A-F by your doctor to see if the treatment is right for you."

The site provides patients with information on A-F symptoms, causes, risks, and current treatments.

For more information on the condition and its link to stroke visit w-w-w-dot-afadvisor-dot-org, or call 1-888-541-7008.

CLICK HERE to download a transcript of this story:
https://www.cpwire.com/click.asp?feature=https://216.86.33.66/stroke.doc

CLICK HERE to download a multimedia (MP3) file of this story:
https://www.cpwire.com/click.asp?feature=https://216.86.33.66/stroke.mp3